Source: International Congress 2019 – Tuberculosis: from diagnosis to complications
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
C. Liu (Taipei, Taiwan), Y. Lu (Taipei, Taiwan), W. Chien (Taipei, Taiwan), C. Chung (Taipei, Taiwan). Fenofibrate is associated with higher risk of mortality in patients with tuberculosis infection. 2944

Member's Comments

No comment yet.

Related content which might interest you: Survival and risk factors of mortality among defaulters from treatment of pulmonary tuberculosis Source: Annual Congress 2012 - MDR- and XDR-TB: epidemiological and public health overview Year: 2012 Lymphopenia as a mortality predictor in non HIV pulmonary TB patients Source: Eur Respir J 2004; 24: Suppl. 48, 424s Year: 2004 Smoking is a risk factor for TB infection, but is it an additional mortality risk? Source: Annual Congress 2011 - Management of tuberculosis Year: 2011 Treatment outcome and risk factors of death in elderly patients diagnosed as new cases of tuberculosis Source: Annual Congress 2010 - Prognosis of tuberculosis Year: 2010 Analysis of mortality incidence in patients with pulmonary tuberculosis Source: Eur Respir J 2002; 20: Suppl. 38, 555s Year: 2002 The evaluation of tuberculosis risk in diabetes mellitus patients in a high incidence of tuberculosis region Source: Annual Congress 2010 - Tuberculosis: metabolic insights Year: 2010 Statin use is associated with reduced mortality after respiratory viral infection Source: ERJ Open Res, 7 (1) 00365-2020; 10.1183/23120541.00365-2020 Year: 2021 Ability of the reduced severity rule crb-65 to detect high risk of short-term mortality from pneumonia in elderly patients Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers Year: 2009 Analysis of the risk factors related to in-hospital deaths in patients with tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 504s Year: 2006 Immunosuppression is associated with lower morbidity and mortality in the 2017/2018 influenza epidemic Source: International Congress 2019 – Clinical challenges in respiratory infection Year: 2019 Budesonide is not associated with increased risk of pneumonia in COPD patients Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment Year: 2009 The risk factors in asthma patients for COVID19 infection Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects Year: 2021 The influence of SARS-CoV-2 co-infection and active tuberculosis on the severity of the disease course and mortality. Source: Virtual Congress 2021 – Tuberculosis, COVID-19 and other comorbidities Year: 2021 Smoking as a risk factor mortality in pulmonary tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 191s Year: 2004 Predictive factors for risk of decease in tuberculosis (TB)-HIV co-infected patients Source: Annual Congress 2010 - Tuberculosis in special populations Year: 2010 Prior cardiovascular disease increases long-term mortality in COPD patients with pneumonia Source: Eur Respir J 2014; 43: 36-42 Year: 2004 Risk factors of intrahospital mortality for pulmonary tuberculosis Source: Annual Congress 2007 - Clinical epidemiology of tuberculosis Year: 2007 Glitazones are associated with reduced risk of COPD exacerbations and mortality among patients with diabetes Source: Annual Congress 2011 - COPD: burden of disease, imaging and management Year: 2011 COPD the unseen factor causing increased morbidity and mortality among IHD patients Source: Annual Congress 2009 - COPD case-finding and management in primary care Year: 2009 Who are at risk for tuberculosis recurrence? Source: Annual Congress 2011 - Challenges in tuberculosis control Year: 2011